Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs

Biomaterials

Volumn 17, Issue 8, 1996, Pages 751-758

  Fresta, M ^a   Cavallaro, G ^b   Giammona, G ^b   Wehrli, E ^c   Puglisi, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c LABORATORY OF INORGANIC CHEMISTRY   (Switzerland)

Author keywords

Antiepileptics; Drug delivery; Mechanism of formation; Nanocapsule characterization; Polyethylcyanoacrylate

Indexed keywords

ACRYLIC MONOMERS; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; ELECTRON MICROSCOPY; LAPLACE TRANSFORMS; LASER APPLICATIONS;

ANTIEPILEPTIC DRUGS; FREEZE FRACTURE ELECTRON MICROSCOPY; LASER LIGHT SCATTERING; NANOCAPSULE CHARACTERIZATION; POLYETHYLCYANOACRYLATE (PECA);

BIOMATERIALS;

ACETONE; ALCOHOL; ANTICONVULSIVE AGENT; MIGLYOL; MONOMER; NANOPARTICLE; NONIONIC SURFACTANT; ORGANIC SOLVENT; POLOXAMER; POLY(ETHYL 2 CYANOACRYLATE);

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FREEZE FRACTURE; LASER; LIGHT SCATTERING; POLYMERIZATION; PRIORITY JOURNAL;

EID: 0030131010     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)81411-6     Document Type: Article

References (33)

1. Thies C, Bissery MC. Biodegradable microspheres for patenteral administration. In: Lim F, ed. Biomedical Application of Microencapsulation. Boca Raton, FL: CRC Press, 1984: 53.
2. Gallo JM, Gupta PK, Hung CT, Perrier DG. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. J Pharm Sci 1989; 78: 190-194.
3. Beck LR, Cowser DR, Lewis DH et al. New long-acting injectable microcapsule system for the administration of progesterone. Fertil Steril 1979; 31: 545-551.
4. Lim F, Buchler RJ. Microencapsulation of antibody for use in radioimmunoassay. In: Langrove J, Vunakis HV, eds. Methods in Immunology, Vol. 73, New York: Academic Press, 1981.
5. Bakan JA, Powell TC. Stability of controlled release pharmaceutical microcapsules. In: Roseman TJ, Mansforf SZ, eds. Controlled Delivery Systems. New York: Marcel Dekker, 1983: 177.
6. Donbrow M. Recent advances in microcapsule delivery systems. In: Breimer DD, Speiser P, eds. Topics in Pharmaceutical Sciences. Elsevier: Amsterdam, 1987: 33.
7. Sato T, Kanke M, Schroeder HG, DeLuca PP. Porous biodegradable microspheres for controlled drug delivery. I. Assessment of process conditions and solvent removal techniques. Pharm Res 1988; 5: 21-30.
8. Gurny R, Peppas NA, Harrington DD, Banker GS. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Dev Ind Pharm 1981; 7: 1-25.
9. Edman P, Ekman B, Sjöholm I. Immobilization of proteins in microspheres of biodegradable polyacryldextran. J Pharm Sci 1980; 69: 838-842.
10. Guiot P, Couvreur P. Polymeric Nanoparticles and Microspheres. Boca Raton, FL: CRC Press, 1986.
11. Couvreur P, Vauthier C. Polyalkylcyanoacrylate nanoparticles as a drug carrier: present state and perspectives. J Control Rel 1991; 17: 187-198.
12. Puglisi G, Giammona G, Santagati NA, Carlisi B, Villari A, Spampinto S. Preparation and biological evaluation of ethylcellulose microspheres containing tolmetin. Drug Dev Ind Pharm 1992; 18: 939-959.
13. Guzman M. Formation and characterization of cyclosporine-loaded nanoparticles. J Pharm Sci 1993; 82: 498-502.
14. Marty JJ, Oppenheim RC, Speiser P. Nanoparticles - A new colloidal drug delivery system. Pharm Acta Helv 1978; 53: 17-23.
15. Couvreur P, Kante B, Roland M, Guiot P, Baudhuin P, Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 1979; 31: 331-332.
16. 3]actinomicin D adsorbed on polybutylcyanoacrylate nanoparticles. Int J Pharm 1980; 7: 45-53.
17. Puglisi G, Giammona G, Fresta M, Carlisi B, Micali N, Villari A. Evaluation of polyalkylcyanoacrylate nanoparticles as a potential drug carrier: preparation, morphological characterization and loading capacity. J Microencapsulation 1993; 10: 353-366.
18. Cavallaro G, Fresta M, Giammona G, Puglisi G, Villari A. Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: studies on the possible in vivo application of this colloidal delivery system. Int J Pharm 1994; 111: 31-41.
19. Illum L, Khan MA, Mak E, Davis SS. Evaluation of carrier capacity and release characteristics for poly(2-butyl-2-cyanoacrylate) nanoparticles. Int J Pharm 1986; 30: 17-28.
20. Al Khoury Fallouh N, Rolot-Treupel L, Fassi H, Devissaguet JP, Puisieux F. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int J Pharm 1986; 28: 125-132.
21. Rollot SM, Couvreur P, Roblot-Treupel L, Puisieux F. Physicochemical and morphological characterization of polyisobutylcyanoacrylate nanoparticles. J Pharm Sci 1986; 75: 361-364.
22. Tice TR, Mason DW, Gilley RM. Clinical use and future of parental microspheres delivery systems. In: Prescott LF, Nimmo WS, eds. Novel Drug Delivery and its Therapeutic Application. Chichester: John Wiley & Sons, 1989: 223-235.
23. Gallardo M, Couarraze G, Denizot B, Treupel L, Coureur P, Puisieux F. Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate. Int J Pharm 1993; 100: 55-64.
24. Barrelet J, Tsacopoulos M, Buri P. Cornea preparation for in vitro biopharmaceutical evaluation of ophthalmic dosage forms. J Pharm Pharmacol 1975; 27: 919-922.
25. Puglisi G, Spampinato S, Giammona G, et al. Effect of different ointment bases on ocular anti-inflammatory activity of 4-biphenylacetic acid in the rabbit. Drug Des Deliv 1989; 5: 341-352.
26. Müller M, Meister N, Moor H. Freezing in a propane jet and its application in freeze fracturing. Mikroskopie 1980; 36: 129-140.
27. Chu B. Laser Light Scattering, Academic Press, New York, 1974.
28. Provencher SW, Hendrix J, De Maeyer L, Paulussen N. Direct determination of molecular weight distributions of polystyrene in cyclohexane with photon correlation spectroscopy. J Chem Phys 1978; 69: 4273-4276.
29. Chouinard F, Buczkowski S, Lenearts V. Poly(alkylcyanoacrylate) nanocapsules: physicochemical characterization and mechanism of formation. Pharm Res 1994; 11: 869-874.
30. Leonard F, Kulkarni RK, Brandes G, Nelson J, Cameron JJ. Synthesis and degradation of poly(alkyl α-cyanoacrylates). J Appl Polym Sci 1966; 10: 259-272.
31. Ilium L, Hunneyball IM, Davis SS. The effect of hydrophilic coating on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int J Pharm 1986; 29: 53-65.
32. Hassan EE, Gallo JM. Targeting anticancer drugs to the brain. I: enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J Drug Target 1993; 1: 7-14.
33. Damgè C, Aprahamian M, Balboni G, Hoeltzel A, Andrieu V, Devissaguet JP. Polyalkylcyanoacrylate nanocapsules increase the absorption of a lipophilic drug. Int J Pharm 1987; 36: 121-125.